drugset / Trial / NCT03885895

Treatment of Freckles by Intradermal Tranexamic Acid Versus Q Switched KTP Laser.

NCT03885895

Phase 1 Unknown 30 enrolled Kasr El Aini Hospital
RandomizedSequentialDouble-blindTreatment

Summary

Comparative split face study in which 30 patients with freckles are recruited.One side of the face will be treated with Q Switched (QS)KTP 532nm, and the other side will be treated with intradermal tranexamic acid (TXA).

Timeline

Start
2019-01-15
Primary completion
2019-08
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 1 ml Intrathecal
Comparator Tranexamic Acid Small molecule 100 mg/ml Intrathecal

Indications

No indication recorded.